Co-Authors
This is a "connection" page, showing publications co-authored by Mainul Haque and Jaykaran Charan.
Connection Strength
2.233
-
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021 Sep; 20(9):1125-1136.
Score: 0.953
-
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database. Int J Gen Med. 2021; 14:3909-3927.
Score: 0.240
-
Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review. J Inflamm Res. 2021; 14:2091-2110.
Score: 0.237
-
Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications. Front Pharmacol. 2020; 11:582154.
Score: 0.231
-
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. Expert Rev Clin Pharmacol. 2021 Jan; 14(1):95-103.
Score: 0.230
-
The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population - Public Health Implications. Ther Clin Risk Manag. 2020; 16:1007-1022.
Score: 0.227
-
Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infect Drug Resist. 2020; 13:4427-4438.
Score: 0.057
-
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future. Front Public Health. 2020; 8:585832.
Score: 0.057